SEARCH

SEARCH BY CITATION

References

  • 1
    Sadovnick AD, Ebers GC. Epidemiology of multiple sclerosis: a critical overview. Canadian Journal of Neurological Science 1993; 20: 1729.
  • 2
    AISM (Associazione author Italiana Sclerosi Multiplax)I costi della SM. 2003; Available at http://www.aism.it (accessed Sep 6, 2004).
  • 3
    Trapp BD, Peterson J, Ransohoff RM, et al. Axonal transection in the lesions of multiple sclerosis. New England Journal of Medicine 1998; 338: 278285.
  • 4
    Ebers M. Natural history of multiple sclerosis. In: CompstonA, ed. McAlpine's Multiple Sclerosis, New York, Churchill Livingstone, 1998; pp. 191221.
  • 5
    Freal JE, Kraft GH, Coryell JK. Symptomatic fatigue in multiple sclerosis. Archives of Physical Medicine and Rehabilitation 1984; 65: 135138.
  • 6
    Krupp LB, Alvarez LA, LaRocca NG, Scheinberg LC. Fatigue in multiple sclerosis. Archives of Neurology 1988; 45: 435437.
  • 7
    Lucchinetti CF, Bruck W, Rodriguez M, Lassmann H. Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis. Brain Pathology 1996; 6: 259274.
  • 8
    Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. New England Journal of Medicine 2000; 343: 938952.
  • 9
    Poser CM, Paty DW, Scheinberg L et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Annals of Neurology 1983; 13: 227231.
  • 10
    Mc Donald WI, Compston A, Edan G et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Annals of Neurology 2001; 50: 121127.
  • 11
    Barkhof F, Filippi M, Miller DH et al. Comparison of MR imaging criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997; 120: 20592069.
  • 12
    Tintorè M, Rovira A, Martinez M et al. Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis. American Journal of Neuroradiology 2000; 21: 702706.
  • 13
    Brex FA, Miszkiel KA, O'Riordan JI et al. Assessing the risk of early MS in patients with clinically isolated syndromes: the role of follow-up MRI. Journal of Neurology, Neurosurgery and Psychiatry 2001; 70: 390393.
  • 14
    Fangerau T, Schimrigk S, Haupts M et al. Diagnosis of multiple sclerosis: comparison of the Poser criteria and the new McDonald criteria. Acta Neurologica Scandinavica 2003; 109: 385389.
  • 15
    McDonnell GV, Hawkins SA. Clinical study of primary progressive multiple sclerosis in Northern Ireland, UK. Journal of Neurology, Neurosurgery and Psychiatry 1998; 64: 451454.
  • 16
    Lublin FD, Rengold SC. Defining the clinical course of multiple sclerosis: results from an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials on New Agents in Multiple Sclerosis. Neurology 1996; 46: 907911.
  • 17
    Kurtzke JF. Rating neurological impairment in multiple sclerosis and expanded disability status scale (EDSS). Neurology 1983; 33: 14441452.
  • 18
    Europa. EU at a Glance. European Governments On-Line.Available at 2004; http://www.europa.eu.int/abc/governments/index_en.htm (accessed Sept. 6, 2004).
  • 19
    Rosati G. The prevalence of MS in the world: an update. Neurology Science 2001; 22: 117140.
  • 20
    Pugliatti M, Sotgiu S, Rosati G. The worldwide prevalence of MS. Clinical Neurology and Neurosurgery 2002; 104: 182191.
  • 21
    FirnhaberW, LauerK. (eds) Multiple Sclerosis in Europe: An Epidemiological Update. Darmstadt: Leuchtturm-Verlag/LTV Press, 1994.
  • 22
    Doll R, Hill AB. Mortality of British doctors in relation to smoking: observation on coronary thrombosis. National Cancer Institute Monographs 1966; 19: 205268.
  • 23
    Robertson N, Compston A. Surveying multiple sclerosis in the United Kingdom. Journal of Neurology, Neurosurgery and Psychiatry 1995; 58: 26.
  • 24
    Rothwell PM, Charlton D. High incidence and prevalence of multiple sclerosis in South East Scotland: evidence of a genetic predisposition. Journal of Neurology, Neurosurgery and Psychiatry 1998; 64: 733735.
  • 25
    Swingler RJ, Compston DAS. Demographic characteristics of multiple sclerosis in south East Wales. Neuroepidemiology 1990; 9: 6877.
  • 26
    Roberts MHV, Martin GP, McLelland L et al. The prevalence of multiple sclerosis in the Southampton South West Hampshire Health Authority. Journal of Neurology, Neurosurgery and Psychiatry 1991; 54: 5559.
  • 27
    Mumford CJ, Fraser MB, Wood NW, Compston DAS. Multiple sclerosis in the Cambridge health district of East Anglia. Journal of Neurology, Neurosurgery and Psychiatry 1992; 55: 877882.
  • 28
    Rice-Oxley M, Rees JR, Williams ES. A prevalent survey of multiple sclerosis in Sussex. Journal of Neurology, Neurosurgery and Psychiatry 1995; 58: 2730.
  • 29
    Shepherd DI, Summers A. Prevalence of multiple sclerosis in Rochdale. Journal of Neurology, Neurosurgery and Psychiatry 1996; 61: 415417.
  • 30
    Cook SD, Cromarty MB, Tapp W, Poskanzer D, Wlaker JD, Dowling PC. Declining incidence of multiple sclerosis in the Orkney Islands. Neurology 1985; 35: 545551.
  • 31
    Cook SD, MacDonald J, Tapp W, Poskanzer D, Dowling PC. Multiple sclerosis in the Shetland Islands: an update. Acta Neurologica Scandinavica 1988; 77: 148151.
  • 32
    Allison RS, Millar JH. Prevalence of disseminated sclerosis in Northern Ireland. Ulster Medical Journal 1954; 23: 127.
  • 33
    Forbes RB, Wilson SV, Swingler RJ. The prevalence of multiple sclerosis in Tayside Scotland: do latitudinal gradients really exist? Journal of Neurology 1999; 246: 10331040.
  • 34
    McGuigan C, McCarthy A, Quigley C, Bannan L, Hawkins SA, Hutchinson M. Latitudinal variation in the prevalence of multiple sclerosis in Ireland, an effect of genetic diversity. Journal of Neurology, Neurosurgery and Psychiatry 2004; 75: 572576.
  • 35
    McDonnell GV, Hawkins SA. An epidemiologic study of multiple sclerosis in Northern Ireland. Neurology 1998; 50: 423428.
  • 36
    Robertson NP, Deans J, Fraser M, Compston DAS. multiple sclerosis in the North Cambridgeshire districts of East Anglia. Journal of Neurology, Neurosurgery and Psychiatry 1995; 59: 7176.
  • 37
    Sharpe G, Price SE, Last A, Thompson RJ. Multiple sclerosis in island population-prevalence in the Bailiwicks of Guernsey and Jersey. Journal of Neurology, Neurosurgery and Psychiatry 1995; 58: 2226.
  • 38
    Ford HL, Gerry E, Airey CM et al. The prevalence of multiple sclerosis in the Leeds Health Authority. Journal of Neurology, Neurosurgery and Psychiatry 1998; 64: 605610.
  • 39
    Ford HL, Gerry E, Johnson M, Williams R. A prospective study of the incidence, prevalence and mortality of multiple sclerosis in Leeds. Journal of Neurology 2002; 249: 260265.
  • 40
    McDonnell GV, Hawkins SA. An assessment of the spectrum of disability and handicap in multiple sclerosis: a population-based study. Multiple Sclerosis 2001; 7: 111117.
  • 41
    Dahl OP, Aarseth JH, Myhr KM, Nyland H, Midgard R. Multiple sclerosis in Nord-Trøndelag County Norway: a prevalence and incidence study. Acta Neurologica Scandinavica 2004; 109: 378384.
  • 42
    Celius EG, Vandvik B. Multiple sclerosis in Oslo Norway: prevalence on 1 January 1995 and incidence over a 25-year period. European Journal of Neurology 2001; 8: 463469.
  • 43
    Edland A, Nyland H, Riise T, Larsen JP. Epidemiology of multiple sclerosis in the county of Vestfold, eastern Norway: incidence and prevalence calculations. Acta Neurologica Scandinavica 1996; 93: 104109.
  • 44
    Koch-Henriksen N. The Danish Multiple Sclerosis Registry: a 50-year follow-up. Multiple Sclerosis 1999; 5: 293296.
  • 45
    Larsen JP, Kvaale G, Riise T, Nyland H, Aarli JA. An increase in the incidence of multiple sclerosis in western Norway. Acta Neurologica Scandinavica 1984; 70: 96103.
  • 46
    De Graaf AS. Multiple sclerosis in Northern Norway. European Neurology 1974; 11: 281295.
  • 47
    Grønlie SA, Myrvoll E, Hansen G, et al. Multiple sclerosis in North Norway, and first appearance in an indigeneous population. Journal of Neurology 2000; 247: 129133.
  • 48
    Midgard R, Riise T, Nyland H. Epidemiologic trends in multiple sclerosis in Møre and Romsdal, Norway: a prevalence/incidence study in a stable population. Neurology 1991; 41: 887892.
  • 49
    Groebke-Lorenz W, Balint S, Frey UP et al. Multiple sclerosis in northwestern Switzerland. Schweizerische Medizinische Wochenschrift. Journal Suisse de Medecine 1992; 122: 582587.
  • 50
    Sumelahti ML, Tienari PJ, Wikström J, Palo J, Hakama M. Regional and temporal variation in the incidence of multiple sclerosis in Finland 1979–1993. Neuroepidemiology 2000; 19: 6775.
  • 51
    Midgard R, Riise T, Kvale G, Nyland H. Disability and mortality in multiple sclerosis in western Norway. Acta Neurologica Scandinavica 1996; 93: 307314.
  • 52
    Midgard R, Albrektsen G, Riise T et al. Prognostic factors for survival in multiple sclerosis a longitudinal population based study in Møre and Romsdal, Norway. Journal of Neurology, Neurosurgery and Psychiatry 1995; 58: 417421.
  • 53
    Sundström P, Nyström L, Forsgren L. Prevalence of multiple sclerosis in Västerbotten County in northern Sweden. Acta Neurologica Scandinavica 2001; 103: 214218.
  • 54
    Sundström P, Nyström L, Forsgren L. Incidence (1988–97) and prevalence (1997) of multiple sclerosis in Västerbotten County in northern Sweden. Journal of Neurology, Neurosurgery and Psychiatry 2003; 74: 2932.
  • 55
    Svenningsson A, Runmarker B, Lycke J, Andersen O. Incidence of multiple sclerosis during two fifteen-year periods in the Gothenburg region of Sweden. Acta Neurologica Scandinavica 1990; 82: 161168.
  • 56
    Sundström P, Svenningsson A, Nyström L et al.. Clinical characteristics of multiple sclerosis in Västerbotten County in northern Sweden. Journal of Neurology, Neurosurgery and Psychiatry 2004; 75: 711716.
  • 57
    Sumelahti ML, Tienari PJ, Wikström J, Palo J, Hakama M. Increasing prevalence of multiple sclerosis in Finland. Acta Neurologica Scandinavica 2001; 103: 153158.
  • 58
    Wikström J, Tienari PJ, Sumelahti ML, Hovi E, Kinnunen E, Palo J. Multiple sclerosis in Finland: evidence of uneven geographic distribution, increasing frequency and high familial occurrence. In: FirnhaberW, LauerK, eds. Multiple Sclerosis in Europe: An Epidemiological Update. Darmstadt: Leuchtturm-Verlag/LTV Press 1994; pp 7377.
  • 59
    Sumelahti ML, Tienari PJ, Hakama M, Wikström J. Multiple sclerosis in Finland: incidence trends and differences in relapsing remitting and primary progressive disease courses. Journal of Neurology, Neurosurgery and Psychiatry 2003; 74: 2528.
  • 60
    Koch-Henriksen N, Brønnum-Hansen H, Hyllested K. Incidence of multiple sclerosis in Denmark 1948–1982: a descriptive nationwide study. Neuroepidemiology 1992; 11: 110.
  • 61
    Benedikz J, Magnus S, Gumundsson J et al. The natural history of untreated multiple sclerosis in Iceland. A total population-based 50 year prospective study. Clinical Neurology and Neurosurgery 2002; 104: 208210.
  • 62
    Benedikz JEG, Magnusson H, Poser CM, Gumundsson G. Multiple sclerosis in Iceland 1 January 31 December 1989: a 90 years total population study. In: FirnhaberW, LauerK, eds. Multiple Sclerosis in Europe: An Epidemiological Update. Darmstadt: Leuchtturm-Verlag/LTV Press, 1994; pp. 4150.
  • 63
    Poser S, Stickel B, Krtsch U, Burckhardt D, Nordman B. Increasing incidence of multiple sclerosis: in South Lower Saxony Germany. Neuroepidemiology 1989; 8: 207213.
  • 64
    Lauer K, Firnhaber W. Descriptive and analytical epidemiological data on multiple sclerosis from a long-term study in southern Hesse, Germany. In: FirnhaberW, LauerK, eds. Multiple Sclerosis in Europe: An Epidemiological Update. Darmstadt: Leuchtturm-Verlag/LTV Press, 1994; pp. 147158.
  • 65
    Hein T, Hopfenmüller W. Projection of the number of multiple sclerosis patients in Germany. Nervenartz 2000; 71: 288294.
  • 66
    Poser S. The epidemiology of multiple sclerosis in southern Lower Saxony. In: FirnhaberW, LauerK, eds. Multiple Sclerosis in Europe: An Epidemiological Update. Darmstadt: Leuchtturm-Verlag/LTV Press, 1994; pp. 130133.
  • 67
    Haupts M, Schejbal P, Pohlau D et al. Epidemiological data on multiple sclerosis from an industrial area in north-west Germany. In: FirnhaberW, LauerK, eds. Multiple Sclerosis in Europe: An Epidemiological Update. Darmstadt: Leuchtturm-Verlag/LTV Press, 1994; pp. 143146.
  • 68
    Meyer-Rienecker H. Epidemiological analyses on multiple sclerosis in the region of Rostock, north-east Germany. In: FirnhaberW, LauerK, eds. Multiple Sclerosis in Europe: An Epidemiological Update. Darmstadt: Leuchtturm-Verlag/LTV Press, 1994; pp. 134142.
  • 69
    Beer S, Kesserling J. High prevalence of multiple sclerosis in Switzerland. Neuroepidemiology 1994; 19: 1418.
  • 70
    Baumhackl U, Eibl G, Ganzinger U et al. Prevalence of multiple sclerosis in Austria. Results of a Nationwide Survey. Neuroepidemiology 2002; 21: 226234.
  • 71
    Minderhoud JM, Zwanniken CF. Increasing prevalence and incidence of multiple sclerosis: an epidemiological study in the province of Groningen, The Netherlands. In: FirnhaberW, LauerK, eds. Multiple Sclerosis in Europe: An Epidemiological Update. Darmstadt: Leuchtturm-Verlag/LTV Press, 1994; pp. 113121.
  • 72
    Prange AJA, Lauer K, Poser S et al. Epidemiological aspects of multiple sclerosis: a comparative study of four centres in Europe. Neuroepidemiology 1986; 5: 7179.
  • 73
    Van Ooteghem P, De Hooghe MB, Vlietnick R, Carton H. Prevalence of multiple sclerosis in Flanders, Belgium. Neuroepidemiology 1994; 13: 220225.
  • 74
    Guard O, Pinette T, Dumas R, Giraud M. Épidemiologie de la sclérose en plaques en Cote- D'Or. Sem Hôp Paris 1986; 62: 10551060.
  • 75
    Confavreux C, Darchy P, Alpérovitch A et al. Le Sud-Est français: zone a ‘‘haut risque’’ de sclérose en plaques? Presse Medicale 1987; 16: 622623.
  • 76
    Beer C, Puel J, Clanet M et al. Risk factors in multiple sclerosis: a population-based case–control study in Hautes Pyrénées, France. Acta Neurologica Scandinavica 1989; 80: 4650.
  • 77
    Roth MP, Ballivet S, Descoins P et al. Multiple sclerosis in the Pyrénées-Atlantiques: a case–control study conducted in the southwest of France. In: FirnhaberW, LauerK, eds. Multiple Sclerosis in Europe: An Epidemiological Update. Darmstadt: Leuchtturm-Verlag/LTV Press, 1994; pp. 177178.
  • 78
    Kurtzke JF, Delasnerie-Lauprêtre N. Reflection on the geographic distribution of multiple sclerosis in France. Acta Neurologica Scandinavica 1996; 93: 110117.
  • 79
    Moreau T, Manceau E, Lucas B, Lemesle M, Urbinelli R, Giroud M. Incidence of multiple sclerosis in Dijon, France a population-based ascertainment. Neurological Research 2000; 22: 156159.
  • 80
    Alperovitch A, Bouvier MH. Geographical pattern of death rates from multiple sclerosis in France. An analysis of 4912 deaths. Acta Neurologica Scandinavica 1982; 66: 454461.
  • 81
    Van Bockstael V, Gosselin S, Vukusic S, Confavreux C. Prevalence of multiple sclerosis in French farmers: a national survey. Multiple Sclerosis 2004; 10(Suppl. 2): S156.
  • 82
    Confavreux C, Vukusic S, Adeleine P. Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 2003; 126: 770782.
  • 83
    Potemkowski A. Epidemiology of multiple sclerosis in the region of Szczecin: prevalence and incidence 1993–1995. Neurologia i Neurochirurgia Polska 1999; 33: 575585.
  • 84
    Wender M, Pruchnik-Grabowska D, Hertmanowska H, et al. Epidemiology of multiple sclerosis in Western Poland – a comparison between prevalence rates in 1965 and 1981. Acta Neurologica Scandinavica 1985; 72: 210217.
  • 85
    Potemkowski A, Walczak A, Nocon D, Fabian A, Nowacki P. Epidemiological analysis of multiple sclerosis in the Szczecin Region, north-western part of Poland. In: FirnhaberW, LauerK, eds. Multiple Sclerosis in Europe: An Epidemiological Update. Darmstadt: Leuchtturm-Verlag/LTV Press, 1994; pp. 249254
  • 86
    Berkowicz T. Report of multiple sclerosis center in Lodz. Cephalalgia Hungarica 2004; 13: 6364.
  • 87
    Jedlicka P. Epidemiology of multiple sclerosis in Czechoslovakia. In: BattagliaMA, CrimiG, eds. An Update on Multiple Sclerosis. Monduzzi Editore, Bologna, 1989; pp. 253255.
  • 88
    Jedlicka P, Benes B, Hron B et al. Epidemiology of multiple sclerosis in the Czech Republic. In: FirnhaberW, LauerK, eds. Multiple Sclerosis in Europe: An Epidemiological Update. Darmstadt: Leuchtturm-Verlag/LTV Press, 1994; pp. 261265.
  • 89
    Lensky P. Geographic disproportion of multiple sclerosis in Czechoslovakia from the point of view of indirect proof. In: FirnhaberW, LauerK, eds. Multiple Sclerosis in Europe: An Epidemiological Update. Darmstadt: Leuchtturm-Verlag/LTV Press, 1994; pp. 266273.
  • 90
    Horakova D. Report of multiple sclerosis center at Charles University. Cephalalgia Hungarica 2004; 13: 4748.
  • 91
    Meluzinova E. Report of multiple sclerosis center at University Hospital Motol, 2nd Medical School. Cephalalgia Hungarica 2004; 13: 4950.
  • 92
    Guseo A, Jofeiü E, Kocsis A. Epidemiology of multiple sclerosis in Western Hungary 1957–1992. In: FirnhaberW, LauerK, eds. Multiple Sclerosis in Europe: An Epidemiological Update. Darmstadt: Leuchtturm-Verlag/LTV Press, 1994; pp. 279286.
  • 93
    Palffy G, Czopf J, Kuntar L, Gyodi E . Multiple sclerosis in Baranya County in Hungarians and in Gipsies. In: FirnhaberW, LauerK, eds. Multiple Sclerosis in Europe: An Epidemiological Update. Darmstadt: Leuchtturm-Verlag/LTV Press, 1994; pp. 274278.
  • 94
    Bencsik K, Rajda C, Klivényi P et al. The prevalence of multiple sclerosis in the Hungarian city of Szeged. Acta Neurologica Scandinavica 1998; 97: 315319.
  • 95
    Bencsik K, Rajda C, Füvesi J et al. The prevalence of multiple sclerosis, distribution of clinical forms of the disease and functional status of patients in Csongrád County, Hungary. European Neurology 2001; 46: 206209.
  • 96
    Kurtzke JF. Geographical distribution of multiple sclerosis. An update within special reference to Europe and the Mediterranean region. Acta Neurologica Scandinavica 1980; 62: 6580.
  • 97
    Fernández O, Luque G, San Román C et al. The prevalence of multiple sclerosis in the sanitary district of Vélez-Málaga, southern Spain. Neurology 1994; 44: 425429.
  • 98
    Bufill E, Blesa R, Galàn I, Dean G. Prevalence of multiple sclerosis in the region of Osona, Catalonia, northern Spain. Journal of Neurology, Neurosurgery and Psychiatry 1995; 58: 577581.
  • 99
    Modrego Pardo PJ, Pina Latorre MA, López A, Errea JM. Prevalence of multiple sclerosis in the province of Teruel, Spain. Journal of Neurology 1997; 244: 182185.
  • 100
    Uria DF, Calatayud MT, Virgala P et al. Multiple sclerosis in Gijon health district, Asturias, northern Spain. Acta Neurologica Scandinavica 1997; 96: 375379.
  • 101
    Benito-Léon J, Martín E, Vela L et al. Multiple sclerosis in Móstoles, central Spain. Acta Neurologica Scandinavica 1998; 98: 238242.
  • 102
    Pina MA, Ara JR, Modrego PJ et al. Prevalence of multiple sclerosis in the sanitary district of Calatayud, northern Spain: is Spain a zone of high risk for this disease? Neuroepidemiology 1998; 17: 258264.
  • 103
    Tola MA, Yugueros MI, Fernández-Buey N, Fernández-Herranz R. Prevalence of multiple sclerosis in Valladolid, northern Spain. Journal of Neurology 1999; 246: 170174.
  • 104
    De Sã J, Mendes H, Pallos A et al. The prevalence of multiple sclerosis in Portugal: results of a population-based study. Multiple Sclerosis 1998; 4: 368.
  • 105
    Malatesta G, Gabriele A, Macor S et al. Diffusion of multiple sclerosis in two Italian provinces, Chieti-Pescara. Italian Journal of Neurological Sciences 1991; 12 (Suppl. 5): 83.
  • 106
    Meucci G, Bianchi F, Rossi G. Indagine sulla prevalenza della sclerosi multipla nella USL n.17 del Valdarno inferiore. In: 7th Italian Congress of Neuroepidemiology (Abstract Book).Tipografia Umbra Perugia, 1992; p. 35.
  • 107
    Granieri E, Malagú S, Casetta I et al. Multiple sclerosis in Italy. A reappraisal of incidence and prevalence in Ferrara. Archives of Neurology 1996; 53: 793798.
  • 108
    Maddestra M, Sabbatini S, Paci F, Paci A. Epidemiological survey of multiple sclerosis in the province of Terni. Neuroepidemiology 1998; 17: 54.
  • 109
    Totaro R, Marini C, Cialfi A et al. Prevalence of multiple sclerosis in the L'Aquila district, central Italy. Journal of Neurology, Neurosurgery and Psychiatry 2000; 68: 349352.
  • 110
    Iuliano G. Prevalence of multiple sclerosis in Salerno, Italy: preliminary data in a study on general practitioners. Italian Journal of Neurological Sciences 1999; 20 (Suppl. 4): S186.
  • 111
    Sironi L, D'Alessandro G, Corso G, Bottacchi E. Epidemiology of multiple sclerosis in Valle d'Aostam, Italy. Multiple Sclerosis 1997; 3: 283.
  • 112
    Ranzato F, Perini P, Tzintzeva E et al. Increasing frequency of multiple sclerosis in Padova, Italy: a 30-year epidemiological survey. Multiple Sclerosis 2003; 9: 387392.
  • 113
    Nicoletti A, Lo Bartolo ML, Lo Fermo S et al. Prevalence and incidence of multiple sclerosis in Catania, Sicily. Neurology 2001; 56: 6266.
  • 114
    Granieri E, Casetta I, Govoni V et al. The increasing incidence and prevalence of M S in a Sardinian province. Neurology 2000; 55: 842847.
  • 115
    Pugliatti M, Sotgiu S, Solinas G et al. Multiple sclerosis epidemiology in Sardinia: evidence for a true increasing risk. Acta Neurologica Scandinavica 2001; 103: 2026
  • 116
    Sotgiu S, Pugliatti M, Sanna A et al. Multiple sclerosis complexity in selected populations the challenge of Sardinia, insular Italy. European Journal of Neurology 2002; 9: 329341.
  • 117
    Dean G, Elian M, Galea de Bono A et al. Multiple sclerosis in Malta in 1999: an update. Journal of Neurology, Neurosurgery and Psychiatry 2002; 73: 256260.
  • 118
    Koncan-Vracko B. Epidemiological investigation of multiple sclerosis in Slovenia. In: FirnhaberW, LauerK, eds. Multiple Sclerosis in Europe: An Epidemiological update. Darmstadt: Leuchtturm-Verlag/LTV Press, 1994; p. 294.
  • 119
    Materljan E, Sepcic J. Epidemiology of multiple sclerosis in Croatia. Clinical Neurology and Neurosurgery 2002; 104: 192198.
  • 120
    Pekmezovic T, Jarebinski M, Drulovic J, Stojsvljevic N, Levic Z. Prevalence of multiple sclerosis in Belgrade, Yugoslavia. Acta Neurologica Scandinavica 2001; 104: 353357.
  • 121
    Ljapchev R, Daskalovska V. Epidemiological studies of multiple sclerosis in the Republic of Macedonia. In: FirnhaberW, LauerK, eds. Multiple Sclerosis in Europe: An Epidemiological Update. Darmstadt: Leuchtturm-Verlag/LTV Press, 1994; pp. 301308.
  • 122
    Petrescu A, Verdes F. Epidemiology of multiple sclerosis in Romania. Neurologie et Psychiatrie (Bucur) 1989; 27: 261271.
  • 123
    Petrescu A. Epidemiology of multiple sclerosis in Romania. In: FirnhaberW, LauerK, eds. Multiple Sclerosis in Europe: An Epidemiological Update. Darmstadt: Leuchtturm-Verlag/LTV Press, 1994; pp. 287293.
  • 124
    Becus T, Popoviciu L. Epidemiologic survey of multiple sclerosis in Mures County, Romania. Romanian Journal of Neurology and Psychiatry 1994; 32: 115122.
  • 125
    Bajenaru O, Pascu I. Report of multiple sclerosis centers. Cephalalgia Hungarica 2004; 13: 6870.
  • 126
    Milanov I, Georgiev D, Kmetska K, Jordanova L, Topalov N. Prevalence of multiple sclerosis in Bulgaria. Neuroepidemiology 1997; 16: 304307.
  • 127
    Milanov I, Topalov N, Kmetska TS. Prevalence of multiple sclerosis in Gipsies and Bulgarians. Neuroepidemiology 1999; 18: 218222.
  • 128
    Trendafilova L, Manova M, Hadjipetrova . K Multiple sclerosis in the Plovdiv area, Bulgaria. In: FirnhaberW, LauerK, eds. Multiple Sclerosis in Europe: An Epidemiological Update. Darmstadt: Leuchtturm-Verlag/LTV Press, 1994; pp. 326331.
  • 129
    Rose AS, Ellison GW, Myers LW, Tourtellotte WW. Criteria for the clinical diagnosis of multiple sclerosis. Neurology 1976; 26: 2022.
  • 130
    Kruja J. Multiple sclerosis in Albania. In: FirnhaberW, LauerK, eds. Multiple Sclerosis in Europe: An Epidemiological Update. Darmstadt: Leuchtturm-Verlag/LTV Press, 1994; pp. 309315.
  • 131
    Piperidou HN, Heliopoulos IN, Maltezos ES, Milonas IA. Epidemiological data of multiple sclerosis in the province of Evros, Greece. European Neurology 2003; 49: 812.
  • 132
    Middleton LT, Dean G. Multiple sclerosis in Cyprus. Journal of the Neurological Sciences 1991; 103: 2936.
  • 133
    Dean G, Aksoy H, Akalin T, Middleton L, Kyriallis K. Multiple sclerosis in the Turkish- and Greek-speaking communities of Cyprus. A United Nations Bicommunal Project. Journal of the Neurological Sciences 1997; 145: 163168.
  • 134
    Çelik Y, Birgili O, Kiyat A et al. Prevalence of multiple sclerosis in the metropolitan area of Edirne city, Turkey. Multiple Sclerosis 2003; 9 (Suppl. 1)): 4748. Abstract.
  • 135
    Boiko AN. Multiple sclerosis prevalence in Russia and other countries of the former USSR. In: FirnhaberW, LauerK, eds. Multiple Sclerosis in Europe: An Epidemiological Update. Darmstadt: Leuchtturm-Verlag/LTV Press, 1994; pp. 219230.
  • 136
    Boiko A, Deomina T, Favorova O, Gusev E, Sudomoina M, Turetskaya R. Epidemiology of multiple sclerosis in Russia and other of the former Soviet Union: investigations of environmental and genetic factors. Acta Neurologica Scandinavica 1995; 91 (Suppl. 161): 7176.
  • 137
    Gross K, Kokk A, Kaasik AE. Prevalence of MS in South Estonia. Evidence of a new border of the Fennoscandian focus. Acta Neurologica Scandinavica 1993; 88: 241246.
  • 138
    Korbut AL, Korniychuk AG. MS in the population of Vinnytsya City Central Ukraine.2001; Neurologia; neurochirurgia Polska. (Suppl. 2): 160.
  • 139
    Korniychuk AG, Zheliba OV. Epidemiology of MS in Vinnytsia Oblast, South-West Ukraine. Journal of Neuroimmunology 2005; 56–63 (Suppl. 1): 41.
  • 140
    Boiko A, Zavalishin IA, Spirin NN et al. Epidemiology of MS in Russia: first data of United Study of Multiple Sclerosis epidemiology in Russia. Multiple Sclerosis 2004; 10 (Suppl.2): 157. Abstract.
  • 141
    Lai SM, Zhang ZX, Alter M, Sobel E. World-wide trends in multiple sclerosis mortality. Neuroepidemiology 1989; 8: 5667.
  • 142
    Brønnum-Hansen H, Koch-Henriksen N, Stenager E. Trends in survival and cause of death in Danish patients with multiple sclerosis. Brain 2004; 127: 844850.
  • 143
    Ekestern E, Lebhart G. Mortality from multiple sclerosis in Austria 1970–2001: dynamics, trends and prospects. European Journal of Neurology 2004; 11: 511520.
  • 144
    Tassinari T, Parodi S, Badino R, Vercelli M. Mortality trend for multiple sclerosis in Italy (1974–1993). European Journal of Epidemiology 2001; 17: 105110.
  • 145
    Landtblom AM, Riise T, Boiko A, Soderfelt B. Distribution of multiple sclerosis in Sweden based on mortality and disability compensation statistics. Neuroepidemiology 2002; 21: 167179.
  • 146
    Kantarci O, Siva A, Eraksoy M et al. Survival and predictors of disability in Turkish MS patients. Neurology 1998; 51: 765772.
  • 147
    Pekmezovic T, Jarebinski M, Drulovic J, Stojsavljevic N, Levic Z. Survival of multiple sclerosis patients in the Belgrade population. Neuroepidemiology 2002; 21: 235240.
  • 148
    Sumelahti ML, Tienari PJ, Wikström J, Salminen TM, Hakama M. Survival of multiple sclerosis in Finland between 1964 and 1993. Multiple Sclerosis 2002; 8: 350355.
  • 149
    Zivadinov R, Iona L, Monti-Bragadin L et al. The use of standardized incidence and prevalence rates in epidemiological studies on multiple sclerosis. Neuroepidemiology 2003; 22: 6574.
  • 150
    Murray CJL, Lopez AD. Progress and directions in refining the global burden of disease approach: a response to Williams. Health Economics 2000; 9: 6982.
  • 151
    Fox-Rushby JA, Hanson K. Calculating and presenting disability adjusted life years (DALYs) in cost-effectiveness analysis. Health Policy Planning 2001; 16: 326331.
  • 152
    World Health Organization (2004). Statistical Annex. The World Health Report 2004 – Changing History. Geneva: WHO.
  • 153
    Global Health Atlas. 2005; Available at http://atlas.globalhealth.org (accessed June 14, 2005).